Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? (Q47734769)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 1998

edit

Language	Label	Description	Also known as
English	Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?	scientific article published in February 1998

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

meta-analysis

0 references

title

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

main subject

meta-analysis

0 references

author

Thierry Poynard

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

author name string

Mathurin P

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

Rixe O

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

Carbonell N

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

Bernard B

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

Cluzel P

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

Bellin MF

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

Khayat D

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

Opolon P

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

language of work or name

English

0 references

publication date

1 February 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

published in

Alimentary Pharmacology & Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

page(s)

111-126

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

cites work

A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cooperative Study Group for Liver Cancer Treatment in Shikoku area

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

5-Fluorouracil in hepatocellular carcinoma.Report of twenty-one cases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Neocarzinostatin versus m-AMSA or doxorubicin in hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: An RTOG study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Primary liver cancer. An Eastern Cooperative Oncology Group Trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Surgical resection and survival in Western patients with hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Meta-analyses of randomized controlled trials.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Methods for combining randomized clinical trials: strengths and limitations.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Meta-analysis in clinical trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Natural history of hepatocellular carcinoma in Spain

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection,

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00286.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1365-2036.1998.00286.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

PubMed publication ID

9692685

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9692685

retrieved

5 February 2018

reference URL

http://europepmc.org/abstract/MED/9692685

ResearchGate publication ID

13591943

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47734769&oldid=1208350602"